Skip to main content
SpringerLink
Log in

Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: A Southwest Oncology Group study

  • Letter to the Editor
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aisner J, Wiernik PH: Malignant mesothelioma. Chest 74:438–444, 1978

    Google Scholar 

  2. Von Hoff DD: Personal communication

  3. Valeriote FA, Bruce WR, Meeker BE: A model for the action of vinblastine in vivo. Biophys J 6:145–152, 1966

    Google Scholar 

  4. Yap RY, Blumenschein GR, Keating MJ, Hortobagyi GN, Tashima CK, Loo TL: Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer. Cancer Treat Rep 64:279–283, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mountain Cancer Treatment Center, 37801, Maryville, TN, USA

    John D. Cowan

  2. Southwest Oncology Group Biostatistical Center, 98104, Seattle, WA, USA

    Stephanie Green

  3. Ohio State University Health Center, 43210, Columbus, OH, USA

    Joel Lucas

  4. Cleveland Clinic Foundation, 44106, Cleveland, OH, USA

    James K. Weick

  5. Ohio State University Health Center, 43210, Columbus, OH, USA

    Stanley P. Balcerzak

  6. Puget Sound Oncology Consortium, 98104, Seattle, WA, USA

    Saul E. Rivkin

  7. Puget Sound Oncology Consortium, 98104, Seattle, WA, USA

    Charles A. Coltman

  8. Wayne State University, 48201, Detroit, MI, USA

    Laurence H. Baker

Authors
  1. John D. Cowan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie Green
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joel Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James K. Weick
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stanley P. Balcerzak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Saul E. Rivkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Charles A. Coltman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Laurence H. Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cowan, J.D., Green, S., Lucas, J. et al. Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: A Southwest Oncology Group study. Invest New Drugs 6, 247–248 (1988). https://doi.org/10.1007/BF00175408

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175408

Keywords

Search

Navigation